Lyterian Therapeutics

Lyterian Therapeutics

生物技术研究

South San Francisco,California 1,870 位关注者

Co-opting physiologically relevant protein homeostatic mechanisms for treating disease

关于我们

Lyterian Therapeutics derives its name from the Greek word λυτ?ριο? or lut?rios, that defines the termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. We are inspired to learn from the logic that orchestrates homeostatic equilibria and fosters healing in response to disease. At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically validated targets.

网站
lyterian.com
所属行业
生物技术研究
规模
11-50 人
总部
South San Francisco,California
类型
私人持股
创立
2022
领域
Biotechnology和Pharmaceuticals

地点

  • 主要

    630 Gateway Blvd

    US,California,South San Francisco,94080

    获取路线

Lyterian Therapeutics员工

动态

相似主页